Hallucinogen pharmacology and effects

The manuals converge on the need for working knowledge of psilocybin’s acute time course, expected subjective effects, and common physical reactions. Across the extracts, psilocybin is described as producing altered perception, changes in mood and cognition, anxiety or emotional lability, and transient increases in blood pressure or heart rate, with nausea, headache, dizziness, and similar effects also recurring. Several sources also link this knowledge to preparation, monitoring, reassurance, and distinguishing expected psychedelic phenomena from concerning reactions. They also converge on the idea that hallucinogen effects may be therapeutically relevant, not merely side effects. The extracts repeatedly mention set and setting, psychotherapy as the treatment frame, and possible links between strong subjective or mystical-type experiences and outcomes such as insight, motivation, spirituality, meaning-making, or behaviour change. Some manuals extend this to persisting effects on mood, anxiety, values, openness, and spirituality. The main differences are in emphasis and scope. Some manuals focus more on psilocybin specifically, while others cover LSD or compare psilocybin with risperidone or diphenhydramine. Safety detail also varies, with some sources stressing rare psychiatric risks such as psychosis, mania, HPPD, or suicidality, and others emphasising medical screening issues such as serotonergic interactions, QT-related risk factors, elevated resting blood pressure or heart rate, and other exclusion criteria.